MCQs - 2026-04

This success points towards the era of precision medicine, where treatments are tailored to an individual's genetic makeup, offering highly targeted and effective therapies.

The trial demonstrates the significant therapeutic potential of CRISPR technology in treating human genetic diseases, particularly those affecting vision.

The trial focused on Leber congenital amaurosis (LCA), a severe form of inherited blindness caused by mutations in genes like RPE65.

The trial utilized CRISPR-Cas9, a revolutionary gene-editing tool known for its precision and efficiency in modifying DNA.

Gene therapy aims to address the root cause of genetic disorders by modifying or replacing the defective genes that lead to the disease.

The development of Vigyan-1 involves collaboration between ISRO (public sector) and private aerospace companies, showcasing the importance of public-private partnerships in advancing India's space capabilities.

By launching its own commercial space station module, India is positioning itself as a participant and potential leader in the expanding global commercial space economy.

Microgravity offers unique conditions for research in fields like medicine (e.g., protein crystallization for drug development) and materials science (e.g., creating new alloys).

The Indian Space Research Organisation (ISRO) is collaborating with private aerospace companies on the development and deployment of Vigyan-1.

Vigyan-1 is designed as a commercial space station module, intended for scientific experiments, technology demonstrations, and potentially space tourism.